Related Experiment Videos
Body composition and mortality in chronic obstructive pulmonary disease
Annemie M W J Schols1, Roelinka Broekhuizen, Clarie A Weling-Scheepers
1Department of Respiratory Medicine, University of Maastricht, Maastricht, Netherlands. a.schols@pul.unimaas.nl
The American Journal of Clinical Nutrition
|July 9, 2005
Summary
Low fat-free mass, not fat mass, independently predicts mortality in chronic obstructive pulmonary disease (COPD) patients. Body composition assessment is crucial for staging COPD severity.
Area of Science:
- Pulmonary Medicine
- Clinical Nutrition
- Gerontology
Background:
- Chronic obstructive pulmonary disease (COPD) patients with lower body weight exhibit higher mortality rates.
- Existing survival studies indicate a paradox where underweight and normal-weight COPD patients face greater mortality than overweight or obese individuals.
Purpose of the Study:
- To investigate the independent contributions of low fat-free mass and low fat mass to mortality risk in COPD.
- To assess the association between specific body composition metrics and overall mortality in a cohort of COPD patients.
Main Methods:
- A cohort of 412 patients with moderate-to-severe COPD (GOLD stages II-IV) was studied.
- Body composition was evaluated using single-frequency bioelectrical impedance, calculating fat-free mass index and fat mass index.
- Patients were categorized by tissue-depletion patterns, and mortality was tracked over a 5-year follow-up period.
Main Results:
- Forty-six percent of the COPD patients died during the follow-up period.
- Fat-free mass index emerged as an independent predictor of survival (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), even after adjusting for disease severity.
- Fat mass index did not show a significant association with mortality; cachexia and muscle atrophy prevalence did not significantly differ between survival groups.
Conclusions:
- Reduced fat-free mass is a significant, independent predictor of mortality in COPD patients, regardless of their fat mass.
- Body composition analysis, particularly fat-free mass, should be considered a systemic marker for assessing COPD disease severity and prognosis.